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ABSTRACT 
 
 
 
Cryptococcosis, infection with a fungus in the Cryptococcus genus, usually 
neoformans, is responsible for the deaths of hundreds of thousands of 
immunocompromised individuals worldwide annually.  We hypothesized that the 
type of polarization of lung macrophage cells that form during infection of a murine 
model will provide evidence for the mechanisms of protection against this pathogen.  
We used flow cytometric analyses to assay specific marker proteins on macrophage 
cells recruited to the mouse lung during infection with various virulent C. 
neoformans strains.  The results identified a previously unobserved factor that helps 
determine whether the mouse succumbs to infection, and the project shifted to 
examine distinct eosinophil populations recruited by the murine strains that were 
most susceptible to Cryptococcus.  This information will hopefully aid in the Levitz’s 
lab development of a vaccine against C. neoformans. 
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BACKGROUND 
 
 
 
 Cryptococcus neoformans is a fungus that most people come into contact with 
daily.  The presence of this opportunistic pathogen in the environment is usually 
innocuous for the majority of the population, as it typically does not affect 
immunocompetent individuals.  First identified as a human pathogen in 1894, 
Cryptococcus neoformans is responsible for approximately 700,000 deaths 
worldwide annually, mostly affecting individuals with repressed immune systems 
(Casadevall and Perfect, 1998; CDC, 2016).  The Cryptococcus problem persists; 
there is no available vaccine for the fungus, and current treatments have many side 
effects.  While medical advances over the past century have helped prolong human 
life expectancy and the quality of life, the ability to knock down the immune system 
for some medical treatments has increased the pool of immunocompromised hosts 
in which Cryptococcus can reside. 
 
Cryptococcus neoformans and Pathogenesis  
Fungi classified as Cryptococcus are categorized as non-fermentative, urease-
producing yeasts (Casadevall and Perfect, 1998). The fungus can be isolated from 
avian excreta, predominantly pigeon, and from some types of decaying wood (CDC, 
2016).  The fungal cells are protected by a distinguishing polysaccharide capsule 
whose production can be induced both in environmental and infected host settings 
(O’Meara and Alspaugh, 2012).    
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Infection with C. neoformans is termed cryptococcosis. Of the 38 identified 
species of Cryptococcus, reports of human pathogenicity are most often for species 
neoformans and gatii (Casadevall and Perfect, 1998).   Infection can occur upon 
inhalation of fungal spores, but it cannot be passed from human to human (CDC, 
2016).  Yeast cells most often act as the infectious particle of the fungus; at 1.8-2.0 
µm they are small enough to easily aerosolize and penetrate the lung alveoli 
(Rodrigues et al., 1999). The wide geographic range of C. neoformans results in 
regular exposure for most individuals, and immunocompetent people are 
asymptomatic (Merck Manuals, 2016).  However, introduction of cryptococcal 
spores into the pulmonary system of immunocompromised individuals is often fatal, 
and results in 1 million cases of cryptococcal meningitis in T-cell-deficient 
individuals annually (CDC, 2016). If untreated, the pneumonia-like infection in the 
lung can disseminate and attack the central nervous system (CNS) (Steenburger and 
Casadevall, 2003).   
Within the lungs, the fungal cell is phagocytosed by alveolar macrophages 
(Figure-1).  This facultative intracellular pathogen then utilizes the phagocytes to 
spread throughout the body.  Although macrophages normally produce oxidative 
and nitrosative agents to create a hostile environment that kills invading pathogens, 
C. neoformans sometimes survives intracellularly in macrophages, which helps 
disseminate the disease and provides resistance to antifungal agents.   The crossing 
of infected macrophage cells across the blood brain barrier to infect the central 
nervous system is most often fatal.  The mortality for AIDS infected individuals who 
contract cryptococcal meningitis is about 60% (Specht et al., 2015). 
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Figure-1: Diagram of the Uptake of Cryptococcus neoformans Spores by 
Lung Macrophages.  Left Panel denotes the initial interaction of C. 
neoformans with alveolar phagocytic cells, its cell-to-cell movement, and the 
movement of infected macrophages into the circulation.   Right Panel 
denotes the subsequent crossing of infected macrophage cells across the 
blood-brain barrier into the central nervous system (Kronstad et al., 2011). 
 
One mechanism by which C. neoformans survives the hostile intracellular 
environment of the macrophage involves upregulation and secretion of fungal 
virulence factors (Figure-2).  These factors influence the macrophage intracellular 
environment, and the expulsion and transfer of the fungus between cells.  The 
factors are delivered by membrane-bound extracellular vesicles that traverse the 
yeast cell wall.  Thus, the Golgi/endosome/exocytosis pathway (diagram center) 
and membrane blebbing from the plasma membrane with captured cytoplasmic 
material (upper diagram) is thought to be important. 
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Figure-2:  Schematic of Cryptococcus neoformans Pathogenesis.  Shown 
are the secretion of virulence factors either by the Golgi-endosome-
exocytosis pathway (diagram center), and the blebbing of the plasma 
membrane containing captured cytoplasmic material (upper diagram) 
(Kronsted et al., 2011) 
 
The fungal virulence factors thought to be important in a C. neoformans 
infection (Table-1) include the synthesis and secretion of the polysaccharide 
capsule, the enzyme laccase (which synthesizes melanin), phospholipase-B, and 
urease (also shown as colored items in Figure-1).   The defensive capsule is a major 
contributor to the virulence of the fungus.  It is composed mainly of glucuro-
noxylomannan which can inhibit phagocytosis (Rohatgi and Pirofski, 2015).  It can 
also contain melanin which aids in the retention of fungal hydrolytic enzymes by 
binding their products and keeping them nearby and readily available to the fungus 
(Casadevall et al., 2000).  The virulence factor delivery bags released into the 
bloodstream (blue in Figure-2) contain polysaccharides which decrease leukocyte 
migration to the site, phospholipases which are critical in host cell wall destruction, 
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urease which causes a spike in local pH, and laccase which protects against oxidative 
burst by alveolar macrophages (Steenbergen and Casadevall, 2003). 
 
Table-1: Virulence factors of Cryptococcus neoformans and their functions  
in both the environment and pathogenesis (Casadevall et al., 2003) 
 
Potential Vaccines and Implications 
Laboratories worldwide are attempting to manipulate the innate immune 
response to render an effective vaccine against virulent strains of C. neoformans.  
The vaccine would not only have to be effective in fighting an established fungal 
infection, but must also prevent recolonization (Datta and Pirofski, 2006).  
Currently, the treatment for cryptococcal infections is an antifungal regimen, but in 
HIV and organ transplant patients this can lead to Cryptococcus-related immune 
reconstitution inflammatory syndrome (IRIS) which is life threatening (Leopold 
Wagner and Wormley, 2015). However, there is much debate whether any vaccine 
would work in individuals who are already immunocompromised.  The countless 
immune system interactions which both prevent and fight infection must be taken 
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into consideration while developing a vaccine model in immunocompromised 
individuals.  
 
M1 and M2 Macrophage Responses 
 The recruitment of leukocytes, or white blood cells, in response to infection 
is critical in both innate and adaptive immunity (Murphy, 2012).  Maturing in the 
bone marrow from pluripotent hematopoietic stem cells, some leukocytes reside in 
peripheral tissues while others are circulated throughout the lymphatic system 
(Murphy, 2012).  Figure-3 illustrates the types of cells composing the body’s 
leukocyte population.  Leukocytes can be classified as granular or agranular, all 
derived from a common stem cell lineage (Murphy, 2012).  Granular leukocytes are 
phagocytes characterized by nuclei with multiple lobes and the presence of 
cytoplasmic granules (Serhan et al., 2010).   
Macrophages are especially important to this MQP project.  Macrophages are 
agranular leukocytes that are mature monocytes.  Macrophages are present in 
virtually all tissues, and their two major functions in the immune system are to: 1) 
phagocytose invading pathogens, and 2) induce inflammation to signal an immune 
response from other cells (Murphy, 2012).  Based upon the stimuli received by these 
phagocytes, they may be activated to polarize to one of two phenotypes: classically 
activated M1 macrophages stimulated by TH1 Helper cells, or alternatively activated 
M2 macrophages stimulated by TH2 Helper cells (Chávez-Galán et al., 2015; Gordon, 
2003).  The M1 phenotype is defined as macrophages that have been activated by 
IFN- ϒ, have high antigen-presenting capacity, and produce large amounts of toxic 
intermediates, especially iNOS (Montovani et al., 2004). Contrastingly, M2 
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macrophages are activated through IL3/IL4, have high levels of non-opsonic 
receptors, and predominantly utilize the arginase pathway (Gordon, 2003; 
Montovani et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-3: Diagram of Hematopoiesis.  Shown are the main pathways of 
differentiation of hematopoietic stem cells to create the various cellular 
components of blood, including those of interest to this MQP such as: 
macrophages, B-lymphocytes and T-lymphocytes (diagram lower right).  
(Murphy, 2012) 
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Cryptococcus-Macrophage Interactions 
 Lung alveolar macrophages are the first line of defense for the immune 
system to inhaled pathogens (Kirby et al., 2009).  After induction of Cryptococcus 
into the airway, the skewing of macrophages is a major factor determining whether 
an organism will succumb to infection.  Classical macrophage activation and the 
shift towards M1 results in fungicidal cellular products, while unbridled fungal 
growth and exacerbation of disease results from a shift towards M2 (Leopold Wager 
and Wormley, 2015).   
Figure-4 illustrates the effects of macrophage polarization on cryptococcal 
proliferation.  The M2 phenotype (lower portion of the figure) is permissive to 
Cryptococcal growth, while induction of skewing to the favorable M1 phenotype 
(diagram upper) has the potential to aid in vaccine creation.  While it has been 
experimentally demonstrated that M2 macrophages can be completely repolarized 
to M1 macrophages through changes in cytokine concentrations, other factors come 
into play in vivo that must be analyzed before effective therapeutic manipulation of 
the macrophage plasticity can be achieved (Davis et al., 2013).  
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Figure-4: Macrophage Polarization and Cryptococcal Infection.  Shown 
are the shift of lung macrophage cells to an M1 type (lower diagram) or an 
M1 type (upper diagram).  The latter is a more effective response for fighting 
a Cryptococcal infection.  (Leopold-Wager and Wormly, 2015). 
 
Experimental Models and Infections in the Levitz Laboratory at UMMS 
Mice are regularly used as a model organism, and in the Levitz laboratory at 
the University of Massachusetts Medical School, murine models are used to examine 
the effects of cryptococcal infection.  The three murine strains most commonly used 
in this lab and their wild-type blood leukocyte compositions are shown in Table-2. 
Table-2: Leukocyte Composition of Various Murine  
Models in our Lab (Jackson Labs, 2016) 
Murine Strain Percent 
Lymphocytes 
Percent 
Basophils 
Percent 
Monocytes 
Percent 
Neutrophils 
Percent 
Eosinophils 
Balb/C Male 71.9 0.8 0.9 23.1 2.9 
Female 80.6 0.2 0.8 14.8 3.0 
CBA/J Male 76.9 0.3 1.4 17.7 3.3 
Female 79.9 0.2 1.5 15.8 2.2 
C57BL/6 Male 76.7 0.2 1.4 18.5 2.6 
Female 88.6 0.2 0.7 7.4 2.6 
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As key players in the immune response, the leukocyte cells listed in the table above 
are determining factors in whether a murine model will succumb to infection.  The 
Levitz laboratory works most often with two strains of Cryptococcus: Kn99α (kn99) 
and cda1Δ2Δ3Δ (cda123).  Kn99 is a hyper-virulent strain of the fungus which was 
backcrossed ten times with the clinical strain Hn99.  Cda123 is an attenuated 
mutant strain of C. neoformans derived from kn99 which lacks cell wall chitosan 
(Specht et al., 2015). Infections with the same strain of Cryptococcus in different 
murine lines result in varying clearance of the fungal load.  Figure-5 illustrates the 
clearance of a cda123 neoformans infection in C57BL/6 and CBA/J mice (Lee et al., 
unpublished data).  Attenuated cda123 is cleared from the lungs by day 7 post-
infection in both mouse strains, while in contrast, most murine stains are more 
susceptible to virulent kn99 (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-5:  Infection of two Mouse Strains with C. neoformans.  Shown 
are the plots of colony forming units of C. neoformans in C57/BL/6 mice 
(left panel) and CBA/J mice (right panel) (Upadhya, unpublished data).  
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Figure-6 illustrates the test of a vaccination approach using heat killed C. 
neoformans (HK in the diagram).  The figure shows the survival of 4 strains of mice 
infected with heat-killed cda123 as a trial vaccine, and then subsequently challenged 
with a second infection 40 days later.  All unvaccinated mice die around 20 days 
post infection, while the vaccinated A/J, BALB/c and 129 mice show a high rate of 
survival.  The vaccinated C57/BL/6 mice die by day-60.  FACS analysis of leukocyte 
composition revealed that the C57/BL/6 mice have a substantial eosinophil 
population which appears to negatively correlate with a model’s ability to recover 
from infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-6: Test of a Vaccination Approach Using Heat-
Killed C. neoformans.  Survivorship of murine strains 
vaccinated with heat-killed cda123 and then challenged with 
a cryptococcal strain 40 days later (Upadhya, unpublished 
data). 
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PROJECT PURPOSE 
Cryptococcus neoformans infections are opportunistic in immuno-
compromised individuals, and are increasing as a greater portion of the population 
become immunocompromised from the use of immunosuppressive drugs or from 
AIDS.  The long term goal of the Levitz Lab at UMMS is to develop a vaccine which 
will protect against cryptococcal infection in immunocompromised individuals.  C. 
neoformans infects the lungs, and is taken into macrophage cells.  Depending on the 
hormones present and other factors, the infected macrophages can either develop 
down an M1 pathway (desirable for vaccines), or down a M2 pathway. Different 
mouse strains (containing different populations of leukocytes) respond differently 
to C. neoformans infection. The objective of this MQP project was to characterize 
lung macrophages in murine models of post-oral-tracheal injection with 
Cryptococcus, to help uncover the mechanism by which different murine lines 
become protected against virulent strains of the fungus.  The hope was to obtain 
information for eventual therapeutic manipulation of the pathway.   
The initial investigation focused on the use of FACS to monitor the M1 and 
M2 immune responses.  However, it became evident there was a previously 
unobserved factor that determines whether the mouse model succumbs to infection, 
and the project shifted to examine distinct eosinophil populations recruited by the 
murine strains most susceptible to Cryptococcus.  This information will hopefully aid 
in the Levitz’s lab development of a vaccine against the fungus. 
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METHODS 
 
 
Infection of Mice with C. neoformans 
Two strains of Cryptococcus neoformans were used throughout the course of 
these experiments: attenuated cda123 and virulent kn99.  Mouse strains Balb/C, 
C57Bl/6, and CBA/J from Jackson Laboratories were used as murine models.  Mice 
were infected oral-tracheally with 106 CFU of cda123 and 104 CFU of virulent Kn99.  
Mice were euthanized for removal of the lungs to be studied through the procedures 
described below. 
 
Lung Dissociation 
After dissection of murine lungs into single lobes, samples were physically 
and enzymatically dissociated using a Miltenyi Biotec Lung Dissociation Kit.  Lungs 
were added to a gentleMACS C Tube containing 2.4 mL 1X Buffer S, 100 µL Enzyme 
D, and 15 µL Enzyme A.  The C Tubes were then attached upside down to the 
gentleMACS Dissociator and run on program m_lung_01 to begin the mechanical 
dissociation.  Next the tubes were incubated for 30 minutes at 37°C on the MACSmix 
Tube Rotator for continuous rotation to promote enzymatic degradation of the 
extracellular matrix.  After this incubation, the tubes were again placed upside down 
on the gentleMACS Dissociator, and they were run on program m_lung_02 for 
further mechanical dissociation.  The resulting suspension was passed through a 70 
µm filter to remove any remnants of large particles.   
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200 µL of the suspension was transferred to a plate for determination of 
colony forming units (CFU) to validate that the fungal infection took.  200 µL of each 
solution was placed in a 1.5 mL Eppendorf tube.  For kn99 samples the suspension 
was diluted 1:10 with 1X PBS. 15 µL of each dilution from 10-1 to 10-6 were plated.  
For cda123 infected samples, 150 µL of undiluted suspension were dispensed onto 
the plate and spread using a bent pipette tip.  Plates were incubated at 37°C for 48 
hours before colony counts were obtained. 
 
Lung Leukocyte Extraction 
The cell suspension created with the Lung Dissociation Kit was centrifuged 
for 5 minutes at 1500 rpm to pellet to begin the leukocyte extraction.  After 
discarding the supernatant, the pellet was resuspended in 5 mL of 40% Percol (GE 
Healthcare) in a 15 mL conical tube.  The lung cell and 40% Percol mixture was then 
slowly and carefully layered onto 5 mL of 66.67% Percol solution in a 15 mL conical 
tube.  The tube was next centrifuged at 2000 rpm for 20 minutes with no brake to 
create a Percol gradient wherein the leukocytes became isolated at the interface 
between the 40% Percol and 66.7% Percol.  After centrifugation, the top layer of 
Cryptococcus and the 40% Percol solution were pipetted out of the tube and 
discarded.  The leukocyte layer was removed with a P1000 and placed in a new 15 
mL conical tube to be washed with 10 mL of 1X PBS.  This mixture was centrifuged 
at 2000 rpm for 5 minutes to pellet and remove any remaining Percol before being 
resuspended in 1X PBS. 
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Cell Staining 
 A cell count was next obtained for the extracted leukocytes.  10 µL of the cell 
suspension was pipetted into a hemocytometer and counted at 100X magnification 
under the compound microscope.  Cell counts were later used to determine volume 
of suspension necessary depending on the type of staining to be done. 
 After an additional wash in 1X PBS, the pellet was suspended in 100 µL of 
FACS Buffer and transferred to a 1.5 mL Eppendorf tube.  To block FC receptors, 1 
µL of .5 mg/mL FC-Block was added to the tube.  The sample was incubated on ice 
for 20 minutes before two washes with FACS buffer. 
 For cell surface staining, the pellet was resuspended in 100 µL of FACS buffer.  
1 µL of each selected antibody (Table-3) was then added to the tube.   
  Table-3: Antibodies used for Cell Surface Staining 
Antibody Company 
CD45 BD Bioscience 
CD11b eBioscience 
CD11c eBioscience 
Ly6G Bio Legend 
Siglec-F BD Bioscience 
 
After the addition of the antibodies selected from the above table, the sample was 
incubated on ice for 30 minutes.  For samples subject only to surface staining, the 
cells were then washed twice more with FACS buffer.  The final pellet was 
resuspended in 300 µL of FACS buffer and fixed with an additional 300 µL of 4% 
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paraformaldehyde (Electron Microscopy Sciences) in 1X PBS.  Samples were stored 
at 4°C until scheduled FACS analysis.  
 
FACS Analysis 
 The samples created were analyzed by flow cytometry.  The channels for the 
various fluorophores used over the course of experiments are shown in Table-4. 
 
  Table-4: Antibodies and their Fluophores 
Antibody Fluorophore 
CD45 APC-Cy7 
CD11b Pe-Cy7 
CD11c Pe 
Ly6G PerCP-Cy5.5 
Siglec-F Pacific Blue 
 
In addition to the channels selected for specific samples, side scatter, forward 
scatter, forward scatter area, and forward scatter height were also measured by the 
machine.  Single color controls created using OneComp eBeads (eBioscience) were 
run during every FACS session to be used for compensation in further analysis.  The 
raw FACS data was analyzed using FlowJo 5.6.7 software. 
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RESULTS 
 
 
 
 Cases of cryptococcosis, infection with Cryptococcus neoformans, have been 
on the rise as the host range for this opportunistic pathogen increases with the 
population of immunocompromised individuals. In addition to the HIV/AIDS 
epidemic which began in the 1980s, medicine has evolved in such a way that the 
immune system can be suppressed for certain therapies, such as bone marrow 
transplants; so illness is no longer the only way in which the immune system can be 
repressed, and the opportunity for cryptococcal infection has expanded.  In attempts 
to gain insight into mechanisms of protection for vaccine development against the 
fungus, cells recruited to the lungs of murine models during infection with either 
cda123 or Kn99 were observed through FACS analysis. 
 After extraction of leukocytes from the enzymatically and mechanically 
digested murine lungs, the cells were stained using antibodies against CD11b, 
CD11c, CD45, Ly6G, and Siglec-F, on either day 3 or day 7 post-infection. After flow 
cytometric analysis, the raw data was analyzed by FlowJo5.6.7 software.  
Compensation using single color controls was adjusted before selecting for singlets 
and gating out debris (Figure-7). 
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Figure-7: Initial FACS Gating Steps. The first steps in the FlowJo5.6.7 
software were to select for singlets and gate out debris.  Singlet cells were 
selected by graphing forward scatter area (X-axis) against forward scatter 
height (Y-axis) (left panel).  Cell debris was removed by graphing forward 
scatter (X-axis) against side scatter (Y-axis) (right panel).  In this plot, cell 
debris is denoted by a high Y-axis placement, which is minimal in the data 
shown. 
 
 
When these initial steps in the gating process were applied to Kn99 
(virulent) or CDA123 (attenuated) infection of CBA/J, BALB/C, or C57BL/6 mice 
(Figure-8), the FACS analysis revealed a distinct population of high side-scatter 
cells (circled black in the diagram) (granular lymphocytes) that were especially 
predominant in Kn99-infected C57BL/6 mice.  The population was more visible at 
day 7 than day 3, was not observed in the more resistant CBA/J mice, and was 
intermediate in the Balb/C strain (Figure-8). 
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Figure-8: Presence of High Side Scatter Cell Populations in C. neoformans 
Infected Mice. After selecting for singlet cells, and gating out cell debris, a 
population of high side-scatter cells was observed (circled black in the panels).  
The population was best seen in Kn99-infected C57BL/6 mice 7 days post 
infection, and was minimal in CBA/J mice. 
 
 
The plating of lung homogenates for assaying fungal colony forming units 
(CFU) (Figure-9) showed that mice with a larger fungal Kn99 CFU load (beige 
histobars) also harbored a greater high side-scatter cells in their lung leukocytes 
(blue histobars).  The BL/6 mice who have the highest percentage of stained 
leukocytes as high scatter also had the greatest load of Kn99 in the lung. Thus, the 
presence of these high side scatter cells appears to have a positive effect on fungal 
growth. 
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Figure-9: Correlation of C. neoformans Lung Colony Forming Units 
Compared to High Side-Scatter Populations.  Fungal colony forming units 
of C. neoformans Kn99 (beige histobars) increase as the percentage of 
extracted leukocytes with high side scatter (blue histobars) increase. 
 
 Further FACS analysis was conducted with specific surface markers to 
determine the cell types present in the high side-scatter population (Figure-10).  
Additional gating was done to select for CD45+ cells, and to gate out B and T cells. 
 
 
 
 
 
 
 
Figure-10: Final Gating Steps for Additional Analysis of the High Side 
Scatter Population.  CD45+ cells (pan leukocyte marker) were selected for 
(left panel).  Cells which were double negative for CD11b and CD11c were 
gated out to remove B and T cells from the analysis (right panel). 
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The additional gating steps were then applied to C. neoformans-infected mice 
(Figure-11) for cells stained for Siglec-F (strongly expressed on eosinophils and 
alveolar macrophages) against cells which fluoresced for CD11c (found at high 
levels on dendritic cells, but also on monocytes, macrophages, neutrophils, and 
some B-cells).  The Kn99 infected BL/6 mice (susceptible) (left panel) showed a 
very strong population of cells that were high in Siglec-F and low for CD11c (Siglec-
F+, CD11c-).  Due to the high granularity of the cells, it was hypothesized that these 
cells may be eosinophils (Piehler et al., 2011).  
 
Figure-11: FACS Analysis of Leukocyte Populations in Lung 
Homogenates of Kn99 Infected Mice Day-7 Post-Infection. Eosinophil, 
neutrophil, and macrophage populations present in the lungs of infected 
mice were visible.  Susceptible BL/6 mice (left panel) showed the highest 
level of eosinophils (Siglec-F+, CD11c-) (upper left circle).  Percentages are 
not from the total cells analyzed but the percentage of the cells within the 
gate forming that population. 
 
 
To determine the reproducibility of these findings, the FACS assays were 
repeated for both Kn99 and CDA123-infected mice (Figure-12).  Thus, the mice who 
recruit a larger eosinophil and smaller neutrophil population to the lungs during infection, 
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such as the C57BL/6 mice, are more likely to succumb to infection than mice who lack 
this phenotype, such as the CBA/J mice.  
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Figure-12: Summary of Repeated FACS 
Analyses of C. neoformans -Infected Mice.  
Shown are the estimates of eosinophil (light 
blue) and neutrophil (dark blue) cells at day-
3 and day-7 post-infection with attenuated 
CDA123 and virulent Tn99 spores.  
Percentages of populations are based off of 
the total analyzed leukocytes, and are each 
the average of two experiments (N=2). The 
most drastic changes over time can be seen 
in the C57BL/6 mice (bottom left), whose 
eosinophil population surpasses the 
neutrophil population on Day 7 of a Kn99 
infection. 
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DISCUSSION 
 
 
 The initial attempts to analyze lung cell populations in Cryptococcus infected 
murine models for M1 or M2 lung macrophage polarization did not result in clear 
data perhaps due to the plasticity of the macrophages, so the project took a different 
turn to investigate a population of high side-scatter cells (granular leukocytes) 
found to be present in BL/6 mice most likely to succumb to an infection.  FACS 
analysis with Siglec-F and CD11c identified the population of cells as most likely 
being eosinophils, granulocytes known to be Siglec-F+, CD11c-.   The high presence 
of these cells in Tn99-infected mice correlated with a higher fungal load in the lung.  
It appears the recruitment of this population of cells is detrimental to survival of the 
infected organism. 
   C57BL/6 mice exhibit a distinct high side scatter population when infected 
with Kn99 (Figure-8).  This population is not present in the more resistant CBA/J 
mice and Balb/C mice that appear to exhibit an intermediate phenotype.  While it is 
evident that certain murine strains are more susceptible to infections, the exact 
mechanism responsible remains unknown.  The C57BL/6 mice with the high side 
scatter population, happen to be one of the strains more susceptible to Cryptococcus 
infection.  In support of this, the percentage of total cells found in this high side 
scatter population corresponds with the mice harboring the greatest fungal loads of 
virulent Kn99 as assayed by CFU (Figure-9).  The relationship indicates these high 
side scatter cells are not useful in clearance of the infection. 
 Staining of cells for surface markers Siglec-F and CD11c revealed eosinophil 
and neutrophil populations within the group of high side scatter (granulocyte) cells. 
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Both eosinophils and neutrophils are granular leukocytes.  As the total eosinophil 
population in the lung increases, the total neutrophil population tended to decrease 
in mice infected with Kn99 (Figure-12).  As the infection progresses, i.e. from day 3 
to day 7, the eosinophil count increases.  The most drastic shift was seen in the 
C57BL/6 mice where the percentage of eosinophils surpassed the percentage of 
neutrophils by day 7.  Thus, maintaining an appropriate eosinophil-neutrophil 
balance seems to be an important aspect in the effectiveness of the immune 
response to Kn99. 
Mouse models exhibiting a greater high side scatter (granulocyte) population 
also showed a higher eosinophil population, the greatest population being present 
in the day-7 Kn99-infected C57BL/6 mice (Figure-12).  The reason for the 
decreased resistance of the BL/6 mice is unknown, but the strong presence of the 
eosinophils could be part of the driving force behind the susceptibility.  Eosinophils 
secrete IL-4 (Davoine and Lacy, 2014).  IL-4 is a cytokine used by our lab and others 
to skew bone marrow-derived cells to an undesirable M2 phenotype. IL-4 and Th2 
cells drive alternate activation, and even in the presence of M1-promoting IFN-ϒ this 
cytokine is harmful to an organism with Cryptococcal infection (Piehler et al., 2011). 
So, the strong presence of eosinophils in susceptible mice could be promoting an M2 
phenotype, and in turn facilitating fungal growth. 
 To further investigate the response to infection, several experiments could 
be conducted in the future. First, populations of cells could be isolated using the 
FACS sorter, and stained to validate the hypothesized cell types. A survivorship 
study for each of the mouse strains would be helpful in linking the cell types 
recruited to the lung with the ability to fight cryptoccocal infection.  Infection 
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studies in eosinophil knockout mice could also be done to provide information into 
the role of the eosinophil population by viewing effects of their removal. 
Additionally, a Luminex panel quantitating which cytokine proteins are present in 
the supernatant of infected lung homogenates would offer a comprehensive view 
into the biochemical differences between murine strains.  The compilation of all this 
data will offer insight into the mechanics of infection and subsequent immune 
responses, and hopefully aid the development of a vaccine against Cryptococcus 
neoformans.  
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